Abstract:Abstract Background: In humans, the β-like globin genes are encoded from a single locus comprising five globin genes (ε-, Gγ-, Aγ-, δ-, and β-globin in sequence) and their expression is under developmental control. The γ-globin genes (Gγ- and Aγ-) are expressed during fetal life and replaced by adult β-globin after birth. Mutations in the β-globin gene cause β-hemoglobinopathies such as sickle cell disease (SCD) and β-thalassemia. The clinical severity of SCD and β-thalassemia can be mitigated by elevated fetal hemoglobin (HbF) levels, which have been found in individuals with the benign hereditary persistence of fetal hemoglobin (HPFH) syndrome. Thus, reactivating the expression of γ-globin genes is an attractive treatment strategy for β-hemoglobinopathies. Reactivation of γ-globin expression by disrupting the binding of the BCL11A transcriptional repressor complex to the γ-globin gene promoter, provides a novel approach for inducing fetal hemoglobin. Methodology: The BCL11A binds a 5′-TGACCA-3′ element (spanning nucleotides −118 to −113) of globin genes using its three C-terminal Zinc fingers (Znf). The binding efficiency of Znf4, Znf5, and Znf6 was predicted by using in silico tools (SIFT, SNAP, PolyPhen-2, PANTHER, I-Mutant, PROVEAN, SNPs&GO, mCSM, and PhD-SNP), molecular dynamic simulation and homology modelling. K562 cells were electroporated with CRISPR-Cas9 targeting the BCL11A Znf4. Results: The binding energy scores illustrate that deleting Znf5 and Znf6 decreased the binding affinity by ~3.7-fold, whereas deleting Znf4 decreased the affinity by > 70-fold. Using CRISPR-Cas9 genome-editing strategy, we deleted Znf4 (260bp genomic region) within the BCL11A in K562 cell lines. Znf4 deletion resulted in a readily detectable γ-globin increase with a preferential increase in G-gamma. Conclusion: Altogether, our findings highlight the valuable insights for improving gene editing therapy strategies by either deleting Znf4 of BCL11A or the TTGACCA motif to disrupt the interaction between BCL11A and other interacting partners and the γ-globin gene promoter. Complete failure in the protein-protein interactions with functional partners and to the γ-globin gene promoter revealed that Znf4 is a suitable target for disrupting BCL11A-mediated hemoglobin switching. Citation Format: Irfan Hussain, Kainaat Mumtaz, Hammad Hassan, Afsar Ali Mian. Amelioration of hemoglobinopathies by targeted deletion of zinc finger domain within BCL11A gene using CRISPR-Cas9 technology. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 4746.

TR4 and BCL11A Repress γ-globin Transcription via Independent Mechanisms

Structures of human TR4LBD–JAZF1 and TR4DBD–DNA complexes reveal the molecular basis of transcriptional regulation

Identification Of A Novel Testicular Orphan Receptor-4 (Tr4)-Associated Protein As Repressor For The Selective Suppression Of Tr4-Mediated Transactivation

Corepressor Smrt Specifically Represses the Transcriptional Activity of Orphan Nuclear Receptor Hb1f/Hlrh-1

Structural basis for human ZBTB7A action at the fetal globin promoter

Structural Insights into the DNA-Binding Mechanism of BCL11A: The Integral Role of ZnF6

Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer <i>via</i> Bcl-2

TR4 Nuclear Receptor Suppresses HCC Cell Invasion Via Downregulating the EphA2 Expression

A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing

Transcriptional Repressor BCL11A in Erythroid Cells

Roles of Nuclear Orphan Receptors TR2 and TR4 during Hematopoiesis

Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin

Characterization of a Strong Repression Domain in the Hinge Region of Orphan Nuclear Receptor Hb1f/hlrh-1.

[Transcriptional Regulation of Gamma- and Epsilon-Globin Genes by Basic Krüppel-like Factor].

Abstract 4746: Amelioration of hemoglobinopathies by targeted deletion of zinc finger domain within BCL11A gene using CRISPR-Cas9 technology

Bcl11b, A Novel Gata3-Interacting Protein, Regulates T-Helper-2-Cell Differentiation and Function

Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression.

Bcl11b, a Novel GATA3-interacting Protein, Suppresses Th1 While Limiting Th2 Cell Differentiation

The Orphan Nuclear Receptor TR2 Suppresses a DR4 Hormone Response Element of the Mouse CRABP-I Gene Promoter

The Role Of Wdr5 In Silencing Human Fetal Globin Gene Expression